SCYNEXIS, Inc. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
SCYNEXIS, Inc. (SCYX) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $6.00 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2017-05-08
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2017-03-31 was $6.00M.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-12-31 was $5.37M.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2016-03-31 was $0.00.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2015-12-31 was $0.00.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2016 was $12.30M.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2015 was $0.00.
- SCYNEXIS, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2014 was $0.00.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2017-03-31 | $6.00M 10-Q · filed 2017-05-08 | $11.37M derived: sum of 2 quarters · filed 2017-05-08 | ||
| 2016-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $12.30M 10-K · filed 2017-03-13 | ||
| 2016-09-30 | $6.93M 10-Q · filed 2016-11-07 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | $0.00 derived: sum of 2 quarters · filed 2017-05-08 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |